The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...
The rumblings of a biotech bubble are getting louder as the Nasdaq Biotech Index has declined about 14% from its peak of $275.40 on February 25th. The recent volatility is a phenomenon that has not ...
Nasdaq Uncovered features key Nasdaq employees, and the people at the center of the trends shaping the future financial ecosystems. Sign up for our newsletter to get the latest on the transformative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results